Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

New immediate release formulation for deterring abuse of methadone.

Betancourt AO, Gosselin PM, Vinson RK.

Pharm Dev Technol. 2013 Mar-Apr;18(2):535-43. doi: 10.3109/10837450.2012.680598. Epub 2012 Apr 27.

PMID:
22540515
2.

Pharmacokinetics of a new immediate-release methadone tablet formulation with decreased in vitro solubility.

Vinson RK.

Clin Drug Investig. 2012 Jul 1;32(7):487-95. doi: 10.2165/11633550-000000000-00000.

PMID:
22621465
3.

Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.

Gohel M, Bariya SH.

Pharm Dev Technol. 2009;14(6):650-8. doi: 10.3109/10837450902911911.

PMID:
19883254
4.

Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug.

Li XN, Guo HX, Heinamaki J.

J Colloid Interface Sci. 2010 May 1;345(1):46-53. doi: 10.1016/j.jcis.2010.01.029. Epub 2010 Jan 18.

PMID:
20129615
5.
6.

Disintegration of highly soluble immediate release tablets: a surrogate for dissolution.

Gupta A, Hunt RL, Shah RB, Sayeed VA, Khan MA.

AAPS PharmSciTech. 2009;10(2):495-9. doi: 10.1208/s12249-009-9227-0. Epub 2009 Apr 23.

7.

In-vitro and in-vivo characteristics of a modified-release double-pulse formulation for a water soluble drug.

Avramoff A, Domb AJ.

Int J Clin Pharmacol Ther. 2010 Apr;48(4):250-8.

PMID:
20353746
8.

Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors.

Gupta VK, Hariharan M, Wheatley TA, Price JC.

Eur J Pharm Biopharm. 2001 May;51(3):241-8.

PMID:
11343889
9.

Formulation and stability evaluation of ketoprofen sustained-release tablets prepared by fluid bed granulation with Carbopol 971P solution.

Vaithiyalingam SR, Tuliani P, Wilber W, Reddy IK, Khan MA.

Drug Dev Ind Pharm. 2002 Nov;28(10):1231-40.

PMID:
12476869
10.

In vitro dissolution of oral modified-release tablets and capsules in ethanolic media.

Smith AP, Moore TW, Westenberger BJ, Doub WH.

Int J Pharm. 2010 Oct 15;398(1-2):93-6. doi: 10.1016/j.ijpharm.2010.07.031. Epub 2010 Aug 1.

PMID:
20667505
11.

In vitro monitoring of dissolution of an immediate release tablet by focused beam reflectance measurement.

Coutant CA, Skibic MJ, Doddridge GD, Kemp CA, Sperry DC.

Mol Pharm. 2010 Oct 4;7(5):1508-15. doi: 10.1021/mp1001476. Epub 2010 Sep 1.

PMID:
20715796
12.

Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.

Sauer D, Zheng W, Coots LB, McGinity JW.

Eur J Pharm Biopharm. 2007 Sep;67(2):464-75. Epub 2007 Mar 7.

PMID:
17451929
13.

Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.

Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT.

Eur J Pharm Biopharm. 2008 Sep;70(1):289-301. doi: 10.1016/j.ejpb.2008.03.021. Epub 2008 Apr 22.

PMID:
18539015
14.

A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.

Krishnaiah YS, Karthikeyan RS, Satyanarayana V.

Int J Pharm. 2002 Jul 25;241(2):353-66.

PMID:
12100863
15.

Effects of liquisolid formulations on dissolution of naproxen.

Tiong N, Elkordy AA.

Eur J Pharm Biopharm. 2009 Nov;73(3):373-84. doi: 10.1016/j.ejpb.2009.08.002. Epub 2009 Aug 11.

PMID:
19679184
16.

Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity.

Tang L, Khan SU, Muhammad NA.

Pharm Dev Technol. 2001 Nov;6(4):531-40.

PMID:
11775954
17.

Formulation development and in vitro evaluation of theophylline microcapsules.

Ahmad M, Akhtar N, Murtaza G, Hussain SW.

Pak J Pharm Sci. 2012 Jan;25(1):15-9.

PMID:
22186304
18.

Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.

Sammour OA, Hammad MA, Megrab NA, Zidan AS.

AAPS PharmSciTech. 2006 Jun 16;7(2):E55.

19.
20.

Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique.

Singh SK, Srinivasan KK, Gowthamarajan K, Prakash D, Gaikwad NB, Singare DS.

Drug Dev Ind Pharm. 2012 Aug;38(8):961-70. doi: 10.3109/03639045.2011.634810. Epub 2012 Jan 18.

PMID:
22251080
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk